scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH
· Real-Time Price · USD
4.11
-0.01 (-0.24%)
At close: Jun 05, 2025, 3:59 PM
4.00
-2.68%
After-hours: Jun 05, 2025, 06:55 PM EDT
-0.24% (1D)
Bid | 3.65 |
Market Cap | 216.98M |
Revenue (ttm) | 41.98M |
Net Income (ttm) | -90.78M |
EPS (ttm) | -1.92 |
PE Ratio (ttm) | -2.14 |
Forward PE | -14.33 |
Analyst | Buy |
Ask | 4.36 |
Volume | 595,219 |
Avg. Volume (20D) | 478,441 |
Open | 4.10 |
Previous Close | 4.12 |
Day's Range | 4.08 - 4.29 |
52-Week Range | 1.94 - 5.65 |
Beta | 0.36 |
About SCPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SCPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+28.57%
scPharmaceuticals shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
-1.89%
scPharmaceuticals shares are trading higher after the company announced FDA approval for a supplemental new drug application expanding the FUROSCIX indication to include the treatment of edema in patients with chronic kidney disease.